NO930452D0 - Nye farmasoeytiske preparater av 5-(2-klor-1-hydroksyetyl)-4-metyltiazol - Google Patents

Nye farmasoeytiske preparater av 5-(2-klor-1-hydroksyetyl)-4-metyltiazol

Info

Publication number
NO930452D0
NO930452D0 NO1993930452A NO930452A NO930452D0 NO 930452 D0 NO930452 D0 NO 930452D0 NO 1993930452 A NO1993930452 A NO 1993930452A NO 930452 A NO930452 A NO 930452A NO 930452 D0 NO930452 D0 NO 930452D0
Authority
NO
Norway
Prior art keywords
chloro
methyltiazol
hydroxythyl
new pharmaceutical
pharmaceutical preparations
Prior art date
Application number
NO1993930452A
Other languages
English (en)
Other versions
NO303447B1 (no
NO930452L (no
Inventor
Bernard Robin Boar
Alan John Cross
Alfred Richard Green
Curt-Eric Hagberg
Original Assignee
Astra Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astra Ab filed Critical Astra Ab
Publication of NO930452D0 publication Critical patent/NO930452D0/no
Publication of NO930452L publication Critical patent/NO930452L/no
Publication of NO303447B1 publication Critical patent/NO303447B1/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/22—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C07D277/24—Radicals substituted by oxygen atoms

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Epidemiology (AREA)
  • Pain & Pain Management (AREA)
  • Urology & Nephrology (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Psychology (AREA)
  • Vascular Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Medicinal Preparation (AREA)
NO930452A 1990-08-15 1993-02-09 AnalogifremgangsmÕte for fremstilling av et terapeutisk aktivt hydrokloridsalt eller etandisulfonatsalt av 5-(2-klor-1-hydroksyetyl)-4-metyltiazol NO303447B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE9002659A SE9002659D0 (sv) 1990-08-15 1990-08-15 New pharmaceutical formulations
PCT/SE1991/000522 WO1992003134A1 (en) 1990-08-15 1991-08-07 New pharmaceutical formulations of 5-(2-chloro-1-hydroxyethyl)-4-methylthiazole

Publications (3)

Publication Number Publication Date
NO930452D0 true NO930452D0 (no) 1993-02-09
NO930452L NO930452L (no) 1993-02-09
NO303447B1 NO303447B1 (no) 1998-07-13

Family

ID=20380161

Family Applications (1)

Application Number Title Priority Date Filing Date
NO930452A NO303447B1 (no) 1990-08-15 1993-02-09 AnalogifremgangsmÕte for fremstilling av et terapeutisk aktivt hydrokloridsalt eller etandisulfonatsalt av 5-(2-klor-1-hydroksyetyl)-4-metyltiazol

Country Status (26)

Country Link
US (1) US5385921A (no)
EP (1) EP0619734B1 (no)
JP (1) JP3094077B2 (no)
AT (1) ATE164066T1 (no)
AU (1) AU657490B2 (no)
BG (1) BG97446A (no)
CA (1) CA2088775A1 (no)
CZ (1) CZ279586B6 (no)
DE (1) DE69129126T2 (no)
DK (1) DK0619734T3 (no)
ES (1) ES2114891T3 (no)
FI (1) FI930608A7 (no)
HU (1) HUT65821A (no)
IE (1) IE912818A1 (no)
IL (1) IL99169A (no)
IS (1) IS3743A7 (no)
LT (1) LT3978B (no)
LV (1) LV10921B (no)
NO (1) NO303447B1 (no)
NZ (1) NZ239329A (no)
PT (1) PT98688B (no)
RO (1) RO112994B1 (no)
RU (1) RU2093155C1 (no)
SE (1) SE9002659D0 (no)
SK (1) SK8793A3 (no)
WO (1) WO1992003134A1 (no)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE9901658D0 (sv) * 1999-05-06 1999-05-06 Astra Ab New formulation
SE9904177D0 (sv) * 1999-11-18 1999-11-18 Astra Ab Novel compounds
US6699866B2 (en) 2001-04-17 2004-03-02 Sepracor Inc. Thiazole and other heterocyclic ligands for mammalian dopamine, muscarinic and serotonin receptors and transporters, and methods of use thereof
CN103772313B (zh) * 2014-01-02 2015-10-14 郑桂富 一种4-甲基-5-(2-羟乙基)噻唑的合成方法
CN112262814A (zh) * 2020-10-26 2021-01-26 宜宾学院 油樟叶渣发酵床养鸡方法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2825966A1 (de) * 1978-06-14 1980-01-03 Basf Ag Saures galvanisches nickelbad, das sulfobetaine als glanz- und einebnungsmittel enthaelt
GB8600783D0 (en) * 1986-01-14 1986-02-19 Merck Sharp & Dohme N-methyl-d-aspartate receptor antagonists

Also Published As

Publication number Publication date
CZ16693A3 (en) 1994-02-16
ES2114891T3 (es) 1998-06-16
RO112994B1 (ro) 1998-03-30
HUT65821A (en) 1994-07-28
PT98688A (pt) 1992-07-31
CA2088775A1 (en) 1992-02-16
JPH06500097A (ja) 1994-01-06
SK8793A3 (en) 1993-07-07
AU657490B2 (en) 1995-03-16
DK0619734T3 (da) 1998-10-05
DE69129126D1 (de) 1998-04-23
WO1992003134A1 (en) 1992-03-05
IL99169A0 (en) 1992-07-15
IE912818A1 (en) 1992-02-26
IL99169A (en) 1995-10-31
JP3094077B2 (ja) 2000-10-03
HU9300388D0 (en) 1993-04-28
LV10921B (en) 1996-08-20
NZ239329A (en) 1994-11-25
RU2093155C1 (ru) 1997-10-20
BG97446A (bg) 1994-03-24
CZ279586B6 (cs) 1995-05-17
ATE164066T1 (de) 1998-04-15
FI930608L (fi) 1993-02-11
LT3978B (en) 1996-06-25
FI930608A0 (fi) 1993-02-11
AU8409291A (en) 1992-03-17
SE9002659D0 (sv) 1990-08-15
IS3743A7 (is) 1992-02-16
PT98688B (pt) 1999-01-29
US5385921A (en) 1995-01-31
LTIP1714A (en) 1995-09-25
NO303447B1 (no) 1998-07-13
EP0619734A1 (en) 1994-10-19
LV10921A (lv) 1995-12-20
EP0619734B1 (en) 1998-03-18
FI930608A7 (fi) 1993-02-11
DE69129126T2 (de) 1998-07-23
NO930452L (no) 1993-02-09

Similar Documents

Publication Publication Date Title
FI913248A0 (fi) Kontrollerat frigoerande fast farmaceutisk doseringsform.
NO914667L (no) Fremgangsmaate for fremstilling av terapeutisk aktive arylderivater
SE8202961D0 (sv) Cefalosporinderivat och forfarande for deras framstellning
NO905201D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive benzofuran-derivater.
DK0532595T3 (da) Farmakologisk anvendelse af visse cystinderivater
NO910935L (no) Fremgangsmaate for fremstilling av terapeutisk aktive c-bundne pyrazol-derivater.
FI922806A0 (fi) Substituerade 4-fenyl-4 -piperidinkarboxamider med baode lokalbedoevande och smaertstillande effekt samt foerfaranden foer deras framstaellning.
NO900795D0 (no) Fremgangsmaate for fremstilling av nye 2-(1-piperazinyl)-4-fenylcykloalkan-pyrimidinderivater.
NO903941D0 (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive diazepinon-derivater.
ITMI921413A0 (it) Preparazioni farmaceutiche stabili di nicorandil
NO173607C (no) Analogifremgangsmaate for fremstilling av nye terapeutisk aktive tienotriazolo-diazepin-derivater
NO930452D0 (no) Nye farmasoeytiske preparater av 5-(2-klor-1-hydroksyetyl)-4-metyltiazol
TR27833A (tr) Antelmintik'lerin uygulanmasina mahsus ''pour-on'' formülasyonu.
HUP9801829A2 (hu) Benzotiofénszármazékok felhasználása IL-6 hatásainak inhibiálására alkalmas gyógyszerkészítmények előállítására
ZA911452B (en) New use of 5-(2-(tert-butylamino)-1-hydroxyethyl)-m-phenylene-bis(dimethylcarbanate)
RU93004984A (ru) Фармацевтическая композиция на основе 5(2-хлор-1-гидроксиэтил)-4-метилтиазола, применение 5-(2-хлор-1-гидроксиэтил)-4-метил-тиазола для лечения, способ лечения, соли 5-(2-хлор-1-гидроксиэтил)-4-метилтиазола
NO178302C (no) Analogifremgangsmåte for fremstilling av terapeutisk aktive, substituerte 3-tia- henholdsvis 3-oksa-alkylflavoner, samt mellomprodukter for fremgangsmåten
NO911665L (no) Fremgangsmaate for fremstilling av nye nojirimycinderivater
SE9000288D0 (sv) New use
ATE201023T1 (de) Ellipticinederivate, ihre herstellung und diese enthaltende pharmazeutische zubereitungen
NO173504C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive tieno-triazolo-diazepin-derivater
NO163407C (no) Analogifremgangsmaate for fremstilling av nye terapeutisk aktive guaninderivater.

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees

Free format text: LAPSED IN FEBRUARY 2002